- Baird Medical Investment Holdings (BDMD, Financial) hosted advanced microwave ablation training for Malaysian thyroid specialists in China.
- The training program featured expert-led demonstrations, workshops, and live MWA procedure observations.
- This initiative aims to promote global collaboration and the adoption of innovative thyroid treatment techniques.
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) recently organized an intensive clinical training and academic exchange program in Shenzhen, China, aimed at enhancing the skills of Malaysian thyroid specialists in the field of microwave ablation (MWA). This program, held at the Eighth Affiliated Hospital of Sun Yat-sen University and Shenzhen People's Hospital, underscores Baird Medical's commitment to advancing clinical excellence and fostering international collaboration.
Participants in this comprehensive program engaged in a curriculum that included expert-led demonstrations, hands-on workshops, and live observations of MWA procedures conducted by leading specialists. These interactive sessions encouraged in-depth discussions on procedural techniques, patient selection criteria, and post-treatment outcomes, further solidifying international clinical partnerships.
"We were honored to host the esteemed doctors from Malaysia and witness their dedication to advancing minimally invasive care," stated Haimei Wu, Chairwoman of Baird Medical. "These international exchanges are instrumental in accelerating the global adoption of innovative thyroid treatment techniques."
This successful event marks a significant step in Baird Medical's mission to expand global education and elevate clinical proficiency in microwave ablation. The company remains dedicated to empowering healthcare professionals with the tools and expertise necessary to deliver safe, effective, and minimally invasive therapies for thyroid disorders.
